New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion

Background: The prognosis of HCC patients with main portal vein invasion (Vp4) is poor. We retrospectively reviewed the therapeutic outcomes with our new HAIC regimen in treating Vp4 HCC patients. Patients and Methods: Seventy-one patients received the new regimen of combining HAIC (daily infusion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming-Feng, Liang, Huei-Lung, Chiang, Chia-Ling, Tsai, Wei-Lun, Chen, Wen-Chi, Tsai, Cheng-Chung, Chen, I-Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864974/
https://www.ncbi.nlm.nih.gov/pubmed/36675749
http://dx.doi.org/10.3390/jpm13010088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864974/
https://www.ncbi.nlm.nih.gov/pubmed/36675749
http://dx.doi.org/10.3390/jpm13010088

Ejemplares similares